Gina Mazzariello, Chief Legal Officer at Amylyx Pharmaceuticals, Inc. (AMLX), sold 3,678 shares at $3.49 ($13K) on 2025-02-03, disclosed to the SEC on 2025-02-05.
Seasonal sale ($13k) by Chief Legal Officer — this insider has traded AMLX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| AMLX | SELL | 2026-03-04 | $99K | — | Filing → |
| AMLX | SELL | 2026-02-25 | $48K | — | Filing → |
| AMLX | SELL | 2026-02-04 | $51K | — | Filing → |